Treatment with carbon monoxide-releasing molecules and an HO-1 inducer enhances the effects and expression of μ-opioid receptors during neuropathic pain

Anesthesiology

Volumn 118, Issue 5, 2013, Pages 1180-1197

  Hervera, Arnau ^a   Leánez, Sergi ^a   Motterlini, Roberto ^b   Pol, Olga ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b FACULTÉ DE MÉDECINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; DELTA OPIATE RECEPTOR; HEME OXYGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MORPHINE; MU OPIATE RECEPTOR; PROTOPORPHYRIN COBALT;

ALLODYNIA; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HYPERALGESIA; HYPERSENSITIVITY; MALE; MICROGLIA; MOLECULE; MOUSE; NERVE COMPRESSION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCIATIC NERVE INJURY; THERMAL INJURY; WESTERN BLOTTING;

ANALGESICS, OPIOID; ANIMALS; CARBON MONOXIDE; CONSTRICTION, PATHOLOGIC; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENZYME INDUCTION; HEME OXYGENASE-1; HOT TEMPERATURE; INDOLES; MALE; MICE; MICE, INBRED C57BL; MORPHINE; NEURALGIA; ORGANOMETALLIC COMPOUNDS; PAIN MEASUREMENT; PHYSICAL STIMULATION; PROTOPORPHYRINS; RECEPTOR, CANNABINOID, CB2; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU;

EID: 84877574530     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318286d085     Document Type: Article

References (46)

1. Obara I, Przewlocki R, Przewlocka B: Local peripheral effects of mu-opioid receptor agonists in neuropathic pain in rats. Neurosci Lett 2004; 360:85-9
2. Obara I, Makuch W, Spetea M, Schütz J, Schmidhammer H, Przewlocki R, Przewlocka B: Local peripheral antinociceptive effects of 14-O- methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat. Eur J Pharmacol 2007; 558:60-7
3. Guan Y, Johanek LM, Hartke TV, Shim B, Tao YX, Ringkamp M, Meyer RA, Raja SN: Peripherally acting mu-opioid receptor agonist attenuates neuropathic pain in rats after L5 spinal nerve injury. Pain 2008; 138:318-29
4. Obara I, Parkitna JR, Korostynski M, Makuch W, Kaminska D, Przewlocka B, Przewlocki R: Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain. Pain 2009; 141:283-91
5. Hervera A, Negrete R, Leánez S, Martín-Campos J, Pol O: The role of nitric oxide in the local antiallodynic and antihyperalgesic effects and expression of delta-opioid and cannabinoid-2 receptors during neuropathic pain in mice. J Pharmacol Exp Ther 2010; 334:887-96
6. Hervera A, Negrete R, Leánez S, Martín-Campos JM, Pol O: Peripheral effects of morphine and expression of μ-opioid receptors in the dorsal root ganglia during neuropathic pain: Nitric oxide signaling. Mol Pain 2011; 7:25
7. Truong W, Cheng C, Xu QG, Li XQ, Zochodne DW: Mu opioid receptors and analgesia at the site of a peripheral nerve injury. Ann Neurol 2003; 53:366-75
8. Kabli N, Cahill CM: Anti-allodynic effects of peripheral delta opioid receptors in neuropathic pain. Pain 2007; 127:84-93
9. Steiner AA, Branco LG, Cunha FQ, Ferreira SH: Role of the haeme oxygenase/carbon monoxide pathway in mechanical nociceptor hypersensitivity. Br J Pharmacol 2001; 132:1673-82
10. Nascimento CG, Branco LG: Role of the peripheral heme oxygenase-carbon monoxide pathway on the nociceptive response of rats to the formalin test: Evidence for a cGMP signaling pathway. Eur J Pharmacol 2007; 556:55-61
11. Li X, Clark JD: The role of heme oxygenase in neuropathic and incisional pain. Anesth Analg 2000; 90:677-82
12. Li X, Clark JD: Heme oxygenase type 2 participates in the development of chronic inflammatory and neuropathic pain. J Pain 2003; 4:101-7
13. Gordh T, Sharma HS, Azizi M, Alm P, Westman J: Spinal nerve lesion induces upregulation of constitutive isoform of heme oxygenase in the spinal cord. An immunohistochemical investigation in the rat. Amino Acids 2000; 19:373-81
14. Fan W, Huang F, Wu Z, Zhu X, Li D, He H: Carbon monoxide: A gas that modulates nociception. J Neurosci Res 2011; 89:802-7
15. Rosa AO, Egea J, Lorrio S, Rojo AI, Cuadrado A, López MG: Nrf2-mediated haeme oxygenase-1 up-regulation induced by cobalt protoporphyrin has antinociceptive effects against inflammatory pain in the formalin test in mice. Pain 2008; 137:332-9
16. Egea J, Rosa AO, Lorrio S, del Barrio L, Cuadrado A, López MG: Haeme oxygenase-1 overexpression via nAChRs and the transcription factor Nrf2 has antinociceptive effects in the formalin test. Pain 2009; 146:75-83
17. Maicas N, Ferrándiz ML, Devesa I, Motterlini R, Koenders MI, van den Berg WB, Alcaraz MJ: The CO-releasing molecule CORM-3 protects against articular degradation in the K/BxN serum transfer arthritis model. Eur J Pharmacol 2010; 634:184-91
18. Sawle P, Foresti R, Mann BE, Johnson TR, Green CJ, Motterlini R: Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br J Pharmacol 2005; 145:800-10
19. De Backer O, Elinck E, Blanckaert B, Leybaert L, Motterlini R, Lefebvre RA: Water-soluble CO-releasing molecules reduce the development of postoperative ileus via modulation of MAPK/HO-1 signalling and reduction of oxidative stress. Gut 2009; 58:347-56
20. Ferrándiz ML, Maicas N, Garcia-Arnandis I, Terencio MC, Motterlini R, Devesa I, Joosten LA, van den Berg WB, Alcaraz MJ: Treatment with a CO-releasing molecule (CORM-3) reduces joint inflammation and erosion in murine collageninduced arthritis. Ann Rheum Dis 2008; 67:1211-7
21. Guillén MI, Megías J, Clérigues V, Gomar F, Alcaraz MJ: The CO-releasing molecule CORM-2 is a novel regulator of the inflammatory process in osteoarthritic chondrocytes. Rheumatology (Oxford) 2008; 47:1323-8
22. Li X, Clark JD: Spinal cord nitric oxide synthase and heme oxygenase limit morphine induced analgesia. Brain Res Mol Brain Res 2001; 95:96-102
23. Liang D, Li X, Lighthall G, Clark JD: Heme oxygenase type 2 modulates behavioral and molecular changes during chronic exposure to morphine. Neuroscience 2003; 121:999-1005
24. Bennett GJ, Xie YK: A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988; 33:87-107
25. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994; 53:55-63
26. Hargreaves K, Dubner R, Brown F, Flores C, Joris J: A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32:77-88
27. Mika J, Osikowicz M, Rojewska E, Korostynski M, Wawrzczak-Bargiela A, Przewlocki R, Przewlocka B: Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain. Eur J Pharmacol 2009; 623:65-72
28. Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, Green CJ: Carbon monoxide-releasing molecules: Characterization of biochemical and vascular activities. Circ Res 2002; 90:E17-24
29. Clark JE, Naughton P, Shurey S, Green CJ, Johnson TR, Mann BE, Foresti R, Motterlini R: Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 2003; 93:e2-8
30. Devesa I, Ferrándiz ML, Terencio MC, Joosten LA, van den Berg WB, Alcaraz MJ: Influence of heme oxygenase 1 modulation on the progression of murine collagen-induced arthritis. Arthritis Rheum 2005; 52:3230-8
31. Hervera A, Negrete R, Leánez S, Pol O: Potential therapeutic role of carbon monoxide synthesized by heme oxygenase-1 in the attenuation of neuropathic pain via microglial inactivation. Eur J Pain Suppl 2011; 5:54
32. Hervera A, Negrete R, Leánez S, Pol O: Carbon monoxide synthesized by heme oxygenase-1 enhanced the effects and expression of μ-opioid receptors during neuropathic pain in mice. Basic Clin Pharmacol Toxicol 2011; 109:21-2
33. Hervera A, Leánez S, Pol O: The inhibition of the nitric oxidecGMP-PKG-JNK signaling pathway avoids the development of tolerance to the local antiallodynic effects produced by morphine during neuropathic pain. Eur J Pharmacol 2012; 685:42-51
34. Chattopadhyay M, Mata M, Fink DJ: Continuous delta-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathy. J Neurosci 2008; 28:6652-8
35. Gaveriaux-Ruff C, Nozaki C, Nadal X, Hever XC, Weibel R, Matifas A, Reiss D, Filliol D, Nassar MA, Wood JN, Maldonado R, Kieffer BL: Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia. Pain 2011; 152:1238-48
36. Romero-Sandoval A, Nutile-McMenemy N, DeLeo JA: Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury. Anesthesiology 2008; 108:722-34
37. Machelska H, Labuz D, Przewłocki R, Przewłocka B: Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord. J Pharmacol Exp Ther 1997; 282:977-84
38. Ozek M, Uresin Y, Güngör M: Comparison of the effects of specific and nonspecific inhibition of nitric oxide synthase on morphine analgesia, tolerance and dependence in mice. Life Sci 2003; 72:1943-51
39. Toda N, Kishioka S, Hatano Y, Toda H: Modulation of opioid actions by nitric oxide signaling. Anesthesiology 2009; 110:166-81
40. Zhang J, Hoffert C, Vu HK, Groblewski T, Ahmad S, O'Donnell D: Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. Eur J Neurosci 2003; 17:2750-4
41. Costa B, Colleoni M, Conti S, Trovato AE, Bianchi M, Sotgiu ML, Giagnoni G: Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain. Br J Pharmacol 2004; 141:4-8
42. Pol O, Murtra P, Caracuel L, Valverde O, Puig MM, Maldonado R: Expression of opioid receptors and c-fos in CB1 knockout mice exposed to neuropathic pain. Neuropharmacology 2006; 50:123-32
43. Megías J, Guillén MI, Clérigues V, Rojo AI, Cuadrado A, Castejón MA, Gomar F, Alcaraz MJ: Heme oxygenase-1 induction modulates microsomal prostaglandin E synthase-1 expression and prostaglandin E(2) production in osteoarthritic chondrocytes. Biochem Pharmacol 2009; 77:1806-13
44. Watkins LR, Milligan ED, Maier SF: Glial activation: A driving force for pathological pain. Trends Neurosci 2001; 24:450-5
45. Mika J, Osikowicz M, Makuch W, Przewlocka B: Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain. Eur J Pharmacol 2007; 560:142-9
46. Bani-Hani MG, Greenstein D, Mann BE, Green CJ, Motterlini R: Modulation of thrombin-induced neuroinflammation in BV-2 microglia by carbon monoxide-releasing molecule 3. J Pharmacol Exp Ther 2006; 318:1315-22